Drug Shortage Report for LANTUS
Report ID | 138648 |
Drug Identification Number | 02245689 |
Brand name | LANTUS |
Common or Proper name | Lantus |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | INSULIN GLARGINE |
Strength(s) | 100UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 1 |
ATC code | A10AE |
ATC description | INSULINS AND ANALOGUES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2021-04-30 |
Estimated end date | 2021-06-02 |
Actual end date | 2021-05-10 |
Shortage status | Resolved |
Updated date | 2021-05-11 |
Company comments | Transportation delay - The transportation delay is due to the strike at the Montreal Port. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-05-11 | English | Compare |
v4 | 2021-05-10 | French | Compare |
v3 | 2021-05-10 | English | Compare |
v2 | 2021-05-03 | French | Compare |
v1 | 2021-05-03 | English | Compare |
Showing 1 to 5 of 5